CHChad H. Hochberg

Chad H. Hochberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chad H. Hochberg has a total of 165 co-authors. Here are the top co-authors by number of shared publications:

  • David N. Hager

    School of Medicine, Johns Hopkins University, Baltimore, MD, USA

    10 shared publications
  • David N. Hager

    Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland

    6 shared publications
  • Michelle Nuttall Eakin

    Johns Hopkins University Division of Pulmonary and Critical Care Medicine Baltimore, Maryland

    6 shared publications
  • Anna K. Barker

    University of Michigan Division of Pulmonary and Critical Care Ann Arbor, MI

    5 shared publications
  • Catherine Aiyuan Gao

    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA

    5 shared publications
  • Michelle N. Eakin

    Division of Pulmonary and Critical Care Medicine (C. H. H., S. K. S., T. J. I., D. N. H., and M. N. E.), Department of Medicine (S. A. E.), Department of Pediatrics (K. J. P.), the Bloomberg School of Public Health (T. J. I.), Johns Hopkins University, Baltimore, MD; and the Pulmonary, Allergy and Critical Care Division (M. P. K.), Palliative and Advanced Illness Research Center, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    5 shared publications

Latest Publications

  • Open Access

    Eligibility for Early Mobilization in Mechanically Ventilated Adults: A Multicenter Study

    by Bhakti K Patel, Kaveri Chhikara, Snigdha Jain, Krysta Wolfe, Chad H Hochberg, Anna K Barker, Nicholas E Ingraham, Patrick G Lyons, Brenna Park-Egan, Catherine A Gao, et al.

    Rationale: Early mobilization of mechanically ventilated patients within 72 hours of intubation is underutilized despite its known clinical benefits. The most cited barrier to implementation is physiologic instability. Objectives: To quantify eligibility for early mobilization across established physiologic criteria in a multicenter cohort of mechanically ventilated adults and estimate the relative impact of structural and process implementation barriers. Methods: Retrospective cohort of adults receiving invasive mechanical ventilation for ≥4 hours across nine CLIF Consortium health systems (2018–2024) and MIMIC-IV (2008–2022). Four physiologic eligibility criteria, from clinical trials (Chicago, TEAM) and consensus guidelines (Green, Yellow), were applied between 8am and 5pm within 72 hours of intubation. Random-effects meta-analysis compared eligibility across criteria and quantified the relative effect of two implementation barriers: weekday-only availability (structural) and 4-hour continuous eligibility (process). Measurements and Main Results: Among 223,281 hospitalizations, 86.9–95.6% met eligibility for mobilization within 72 hours of intubation across all 4 criteria. Compared with Chicago trials criteria, eligibility was reduced under TEAM (SHR 0.782, 95% CI 0.746–0.820) and Green (SHR 0.631, 0.611–0.651) but not Yellow (SHR 0.990, 0.976–1.005). Restricting eligibility to weekdays (structural) or requiring continuous eligibility (process) each reduced eligibility by 26-39% across all four criteria (SHR range 0.61–0.74); imposing both barriers together reduced eligibility by 45-56% (SHR range 0.44-0.55). Conclusions: Most mechanically ventilated adults met physiologic eligibility criteria for early mobilization within 72 hours of intubation. Structural and process barriers, such as staff availability on weekends and sustained eligibility for care coordination, reduced opportunity more potently than physiologic instability alone.

  • Open Access

    Characteristics associated with culture-positivity versus antibiotic administration in patients with cirrhosis on ICU admission: a retrospective cohort study in 5 hospitals

    by Andrew J. Davis, Chad H. Hochberg, Khyzer B. Aziz, Li Yan, Sarina Sahetya, David N. Hager, Theodore J. Iwashyna

    Objective: To test the hypothesis that selected SIRS and SOFA criteria measured at ICU admission have divergent associations with (1) the development of new culture-confirmed infections and (2) early empiric broad-spectrum antibiotic receipt in critically ill patients with cirrhosis. Design: Retrospective, observational study using electronic health record (EHR) data. Setting: Both community and academic ICUs within a five-hospital health system between July 2017 and December 2025. Subjects: Adult patients >18 years of age diagnosed with cirrhosis admitted to the ICU within 96 hours of hospital admission. Patients transferred from outside facilities and those with positive cultures collected >24 hours before ICU admission were excluded. Interventions: None. Measurements: Multivariable logistic regression tested the association of the most aberrant values in nine SIRS/SOFA vital sign and laboratory parameters measured during the 24 hours prior to ICU admission with (1) the development a newly positive culture collected during the 24 hours before through the 96 hours after ICU admission and (2) receipt of broad-spectrum antibiotics during the 24 hours before through the 24 hours after ICU admission. Main Results: The presence of hyperthermia, hypothermia, hypoxia, or hypotension at ICU admission was associated with both culture positivity and antibiotic receipt. The presence of leukocytosis was associated with antibiotic receipt but not culture positivity. Among patients in the 21.6% of encounters with newly positive cultures, normothermia and normal WBC were common (respectively present in 97.2% and 77.5% of encounters) and associated with antibiotic omission at ICU admission despite the subsequent development culture positivity. Conclusions: Traditional physiologic markers of infection are often absent in critically ill patients with cirrhosis who develop new culture-confirmed infections at ICU admission, possibly contributing to delayed antibiotics. There may be opportunities to improve antibiotic delivery and stewardship at ICU admission in this high-risk population.

  • Open Access

    Antifungal use with and without fungal diagnoses among patients with septic shock in a retrospective multicenter cohort

    by Robert J. Flick, Li Yan, Nicholas A. Bosch, Anica C. Law, Khyzer B. Aziz, Chad H. Hochberg, Joseph Levy, Theodore J. Iwashyna

    INTRODUCTION Sepsis caused by fungal organisms is associated with higher mortality and longer time to diagnosis.(,) Estimates of the incidence of fungal infections among patients with sepsis in the United States have not been reported since 2000 and did not specifically address those with septic shock.() There have since been changes in sepsis management and […] INTRODUCTION Sepsis caused by fungal organisms is associated with higher mortality and longer time to diagnosis.(,) Estimates of the incidence of fungal infections among patients with sepsis in the United States have not been reported since 2000 and did not specifically address those with septic shock.() There have since been changes in sepsis management and […]

  • Open Access

    Antifungal use with and without fungal diagnoses in septic shock across U.S. hospitals, 2022-2024

    by Robert J Flick, Li Yan, Anica C Law, Chad H Hochberg, Joseph Levy, Theodore J. Iwashyna, Nicholas A Bosch

    Septic shock caused by fungal organisms is characterized by high mortality and diagnostic complexity. We used the Premier Healthcare Database to characterize antifungal use and fungal diagnoses among adults with septic shock requiring vasopressors admitted between October 2022 through July 2024. Among 12.8 million admission at 886 hospitals, 554,948 met septic shock criteria and were included for analysis. A fungal diagnosis was established in 11,405 (2.1%) of encounters; of these, 3,565 (31.3%) received intravenous antifungal therapy within one day of vasopressor initiation. In the overall cohort, antifungal therapy was initiated in 29,824 (5.5%) within one day of vasopressor initiation; of these, 3,656 (12.2%) were ultimately diagnosed with a fungal infection. In the 116 hospitals reporting microbiological data, a subgroup of 489 encounters with septic shock and culture-confirmed candidemia was identified. In this subgroup, intravenous antifungal therapy was initiated in 43.8% within one day, 63.8% within three days, and 78.9% within seven days. These findings highlight a profound decoupling between fungal diagnosis and treatment—few patients receiving antifungals were diagnosed with an infection that would be treated by these agents, while less than half of patients with septic shock and candidemia received timely treatment. Strategies for greater precision in empiric antifungal use in septic shock are needed to improve safety, stewardship, and outcomes.

  • Prone Positioning in a North American Cohort of Hypoxemic Patients on Mechanical Ventilation

    by Anna K. Barker, Akihiko Nishimura, Mark Nuppnau, Kevin G. Buell, Patrick G. Lyons, Wan-Ting Liao, Brenna Park-Egan, Benjamin E. Schmid, Nicholas E. Ingraham, Vaishvik Chaudhari, et al.

    Objectives: Despite historically limited adoption of prone positioning, a potentially life-saving guideline-recommended intervention for moderate-severe acute respiratory distress syndrome, its use increased for mechanically ventilated patients during the COVID-19 pandemic. Whether implementation of this guideline-recommended intervention was sustained is unknown. Thus, we aimed to evaluate peri-pandemic trends in proning use. Design: We conducted a retrospective cohort study of proning use among mechanically ventilated adults compared across pre-pandemic (from January 2018 to February 2020), pandemic (from March 2020 to February 2022), and post-pandemic (from March 2022 to December 2024) periods. Setting: Thirty-seven North American hospitals. Patients: Mechanically ventilated patients with persistent moderate-to-severe hypoxemia (Pa o 2 /F io 2 ≤ 150 mm Hg, F io 2 ≥ 0.6, and positive end-expiratory pressure ≥ 5 cm H 2 O). Interventions: Proning within 12 hours of meeting hypoxemia criteria. Measurements and Main Results: Among 5944 proning-eligible patients, 2155 (36.2%) received proning: 11.0% pre-pandemic, 51.9% pandemic, and 25.6% post-pandemic. The adjusted odds ratio (OR) for proning during the pandemic vs. pre-pandemic periods was 7.6 (95% CI, 5.5–10.4), and during the pandemic vs. post-pandemic periods was 2.7 (95% CI, 1.8–3.9). Proning varied widely by hospital and was quantified with median ORs (median change in odds of proning for similar patients admitted at a lower vs. higher proning hospital) of 2.9 (95% credible interval [CrI], 1.9–5.3) pre-pandemic, 1.9 (95% CrI, 1.6–2.3) pandemic, and 2.3 (95% CrI, 1.8–3.3) post-pandemic. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive vs. negative pandemic-period patients had increased proning use (OR, 5.1; 95% CI, 4.1–5.6), as did pandemic-period patients without SARS-CoV-2 compared with pre-pandemic patients (OR, 3.8; 95% CI, 2.7–5.2). The difference in proning use between pandemic SARS-CoV-2 negative and post-pandemic patients was smaller and not significant (OR, 1.3; 95% CI, 0.9–1.8). Conclusions: In a North American cohort of proning-eligible patients, proning increased during the pandemic and then declined. Interventions that improve and sustain implementation of this guideline-recommended intervention are needed.


  • Open Access

    Patterns and outcomes of real-world high-flow nasal cannula use: a multi-hospital retrospective cohort study

    by Diana C. Bouhassira, Chad H. Hochberg, Sarina K. Sahetya, Ann Parker, Khyzer B. Aziz, Li Yan, Theodore John Iwashyna

    Objective: To characterize real-world high-flow nasal cannula use and outcomes. Methods: A retrospective observational study using an electronic health record registry of all adult patients in a five-hospital system between 2017 – 2025. We identified all high-flow nasal cannula episodes, defined as periods of high-flow nasal cannula use containing breaks no longer than 6 […] ABSTRACT Objective: To characterize real-world high-flow nasal cannula use and outcomes. Methods: A retrospective observational study using an electronic health record registry of all adult patients in a five-hospital system between 2017 – 2025. We identified all high-flow nasal cannula episodes, defined as periods of high-flow nasal cannula use containing breaks no longer than 6 […]


  • Open Access

    Association of Ambient Air Pollution Exposure and Acute Respiratory Failure Outcomes in the United States

    by Peter Graffy, Kaveri Chhikara, Shan Guleria, Nicholas Ingraham, Vaishvik Chaudhari, Juan Rojas, Kevin Buell, Sivasubramanium Bhavani, Navya Ramesh, Alexander Ortiz, et al.

    Background: Air pollution is a recognized risk factor for chronic cardiopulmonary disease, but its role in acute respiratory outcomes is unknown. Our objective was to determine the association between ambient air pollution exposure and clinical outcomes of acute respiratory failure.Methods: In this retrospective observational cohort study, data were extracted from ten geographically diverse U.S. health systems from 2018 through 2024. Participants included adult patients admitted to the intensive care unit (ICU) who met clinical criteria for acute respiratory failure within the first 24 hours of hospital admission. The primary study outcomes were in-hospital mortality and duration of invasive mechanical ventilation (IMV). We quantified each patient’s air pollution exposure using their residential county annual average of fine particulate matter (PM2.5) and nitrogen dioxide (NO2) preceding ICU admission.Findings: The study cohort included 166,152 patients (mean age, 61.7 years; 59% male) from 1,555 U.S. counties with wide exposure ranges. For every 10-ppb increase in NO2 exposure, the odds of in-hospital mortality were 9% higher (95% CI, 1.04–1.14). Each 10-µg/m3 increase in PM2.5 was associated with a 6% higher risk of death (95% CI, 1.04- 1.08). Each 10-ppb increase in cumulative NO2 exposure was associated with a 2% increase in duration of IMV (95% CI, 1%–3%; p=0.04), whereas PM2.5 exposure was not significantly associated with ventilation duration. In competing-risks analyses, each 10-ppb increase in NO2 exposure was associated with a 50% higher risk of death (SHR, 1.50; 95% CI, 1.16–1.94), relative to recovery.Interpretation: In this large, nationwide ICU cohort of patients with clinically defined ARF, higher cumulative exposure to ambient air pollution prior to admission was associated with increased adverse outcomes. These findings should inform air quality index thresholds and environmental policy.

  • Open Access

    ICU Implementation Determinants and Delivery of Lung Protective Ventilation

    by Chad H. Hochberg, Sophia A. Emetu, Kevin J. Psoter, Sarina K. Sahetya, Meeta P. Kerlin, Theodore J. Iwashyna, David N. Hager, Michelle N. Eakin


  • Federation, not centralization: a new paradigm for electronic health record–based critical care research

    by Patrick G Lyons, Kevin G Buell, Kathryn A Connell, Matthew A Christensen, Chad H Hochberg, Snigdha Jain, William F Parker, Kaveri Chhikara, Juan C Rojas, Catherine Blebea, et al.


  • Open Access

    Outcomes of patients with hypertensive emergency managed in intensive vs intermediate care settings: a multihospital retrospective cohort study

    by Chad H Hochberg, Li Yan, M Elizabeth Card, Stephen A Berry, Daniel Brodie, Leo Rotello, Amirali Nader, Souvik Chatterjee, Sarina K Sahetya, Theodore J Iwashyna, et al.

    Background: Hypertensive emergency is characterized by end-organ dysfunction due to markedly elevated blood pressure. Although guidelines recommend rapid blood pressure lowering with intravenous antihypertensives and continuous monitoring in an intensive care unit (ICU), many patients are managed in intermediate care (IMC) settings. In this study, we compare outcomes of hypertensive emergency patients admitted to ICU vs IMC settings. Methods: Adult patients in the emergency departments of 3 hospitals were included if they had 2 or more systolic blood pressure measurements greater than 180 mm Hg within 12 hours of one another, were treated with continuous intravenous antihypertensive medications, and were subsequently admitted to an ICU or IMC setting. We excluded patients receiving mechanical ventilation in the emergency department and those presenting with acute coronary syndrome, aortic dissection, or acute cerebrovascular accident. The primary outcome was hospital length of stay (LOS) penalized for death and adjusted for baseline patient features. Secondary outcomes included ICU and IMC LOS and hospital mortality. Process outcomes included arterial line usage, frequency of blood pressure measurements in the first 24 hours, and escalations of care. Lastly, we report the proportion of patients reaching blood pressure targets and/or episodes of hypotension in each setting. Results: Intensive care unit patients (n = 649) were younger, with a male predominance, more frequently received noninvasive respiratory support and were dialysis dependent than IMC patients (n = 629). In an adjusted analysis, there was no difference in time to hospital discharge between patients admitted to ICU vs IMC settings (absolute difference: +0.29 days; 95% CI, –0.07 to 0.70). Similarly, there was no difference in ICU vs IMC LOS, hospital readmission rate, or hospital mortality. Blood pressures were more frequently measured in the ICU, but there was no difference in time to target blood pressure goal. Any hypotensive episode in the first 24 hours was more common in the ICU. Conclusions: In this retrospective observational study of patients with hypertensive emergency, we did not observe significantly different LOS outcomes between patients admitted to ICU vs IMC settings or detect a signal of harm among those admitted to IMC. Intermediate care settings may be a reasonable alternative to ICU admission for select patients with hypertensive emergency.